Study: NCT04829123

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HEC88473 injection
Description: HEC88473 will be provided as a 17 mg/mL solution and will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo will be administered by subcutaneous injection in the abdomen